Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE

NCT02686346

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations
  • Clinique Universitaire Saint-Luc Brussels, Belgium
  • CHU Dinant Godinne Yvoir, Belgium
  • Institut d'Hématologie de Basse Normandie - CHU Côte de Nacre Caen, France
  • APHP-Hôpital Henri Mondor Créteil, France
View all 19 locations
View Trial Details
Completed

A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP

NCT02741388

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU Dijon Dijon, France
  • CHRU de Lille - Hôpital Claude Huriez Lille, France
  • CHU Montpellier - Hôpital Saint Eloi Montpellier, France
View Trial Details
Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

NCT01578967

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, Adult, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Levine Cancer Istitute, Carolinas Health Care system Charlotte, North Carolina, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

NCT00774345

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Pacific Coast Hematology Oncology Fountain Valley, California, United States
  • Kaiser Permanente Medical Group San Diego, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 241 locations
View Trial Details
Completed

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

NCT01118026

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Naval Medical Center -San Diego San Diego, California, United States
  • Saint Helena Hospital St. Helena, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Delaware Clinical and Laboratory Physicians PA Newark, Delaware, United States
View all 55 locations
View Trial Details
Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details

Related conditions